Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Prostate Cancer Drugs Market Size Analysis from 2022 to 2027

1.5.1 Global Prostate Cancer Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Prostate Cancer Drugs Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Prostate Cancer Drugs Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Prostate Cancer Drugs Industry Impact

Chapter 2 Global Prostate Cancer Drugs Competition by Types, Applications, and Top Regions and Countries

2.1 Global Prostate Cancer Drugs (Volume and Value) by Type

2.1.1 Global Prostate Cancer Drugs Consumption and Market Share by Type (2016-2021)

2.1.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2016-2021)

2.2 Global Prostate Cancer Drugs (Volume and Value) by Application

2.2.1 Global Prostate Cancer Drugs Consumption and Market Share by Application (2016-2021)

2.2.2 Global Prostate Cancer Drugs Revenue and Market Share by Application (2016-2021)

2.3 Global Prostate Cancer Drugs (Volume and Value) by Regions

2.3.1 Global Prostate Cancer Drugs Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Prostate Cancer Drugs Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Prostate Cancer Drugs Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Prostate Cancer Drugs Consumption by Regions (2016-2021)

4.2 North America Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

4.10 South America Prostate Cancer Drugs Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Prostate Cancer Drugs Market Analysis

5.1 North America Prostate Cancer Drugs Consumption and Value Analysis

5.1.1 North America Prostate Cancer Drugs Market Under COVID-19

5.2 North America Prostate Cancer Drugs Consumption Volume by Types

5.3 North America Prostate Cancer Drugs Consumption Structure by Application

5.4 North America Prostate Cancer Drugs Consumption by Top Countries

5.4.1 United States Prostate Cancer Drugs Consumption Volume from 2016 to 2021

5.4.2 Canada Prostate Cancer Drugs Consumption Volume from 2016 to 2021

5.4.3 Mexico Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 6 East Asia Prostate Cancer Drugs Market Analysis

6.1 East Asia Prostate Cancer Drugs Consumption and Value Analysis

6.1.1 East Asia Prostate Cancer Drugs Market Under COVID-19

6.2 East Asia Prostate Cancer Drugs Consumption Volume by Types

6.3 East Asia Prostate Cancer Drugs Consumption Structure by Application

6.4 East Asia Prostate Cancer Drugs Consumption by Top Countries

6.4.1 China Prostate Cancer Drugs Consumption Volume from 2016 to 2021

6.4.2 Japan Prostate Cancer Drugs Consumption Volume from 2016 to 2021

6.4.3 South Korea Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 7 Europe Prostate Cancer Drugs Market Analysis

7.1 Europe Prostate Cancer Drugs Consumption and Value Analysis

7.1.1 Europe Prostate Cancer Drugs Market Under COVID-19

7.2 Europe Prostate Cancer Drugs Consumption Volume by Types

7.3 Europe Prostate Cancer Drugs Consumption Structure by Application

7.4 Europe Prostate Cancer Drugs Consumption by Top Countries

7.4.1 Germany Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.2 UK Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.3 France Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.4 Italy Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.5 Russia Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.6 Spain Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.7 Netherlands Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.8 Switzerland Prostate Cancer Drugs Consumption Volume from 2016 to 2021

7.4.9 Poland Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 8 South Asia Prostate Cancer Drugs Market Analysis

8.1 South Asia Prostate Cancer Drugs Consumption and Value Analysis

8.1.1 South Asia Prostate Cancer Drugs Market Under COVID-19

8.2 South Asia Prostate Cancer Drugs Consumption Volume by Types

8.3 South Asia Prostate Cancer Drugs Consumption Structure by Application

8.4 South Asia Prostate Cancer Drugs Consumption by Top Countries

8.4.1 India Prostate Cancer Drugs Consumption Volume from 2016 to 2021

8.4.2 Pakistan Prostate Cancer Drugs Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Prostate Cancer Drugs Market Analysis

9.1 Southeast Asia Prostate Cancer Drugs Consumption and Value Analysis

9.1.1 Southeast Asia Prostate Cancer Drugs Market Under COVID-19

9.2 Southeast Asia Prostate Cancer Drugs Consumption Volume by Types

9.3 Southeast Asia Prostate Cancer Drugs Consumption Structure by Application

9.4 Southeast Asia Prostate Cancer Drugs Consumption by Top Countries

9.4.1 Indonesia Prostate Cancer Drugs Consumption Volume from 2016 to 2021

9.4.2 Thailand Prostate Cancer Drugs Consumption Volume from 2016 to 2021

9.4.3 Singapore Prostate Cancer Drugs Consumption Volume from 2016 to 2021

9.4.4 Malaysia Prostate Cancer Drugs Consumption Volume from 2016 to 2021

9.4.5 Philippines Prostate Cancer Drugs Consumption Volume from 2016 to 2021

9.4.6 Vietnam Prostate Cancer Drugs Consumption Volume from 2016 to 2021

9.4.7 Myanmar Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 10 Middle East Prostate Cancer Drugs Market Analysis

10.1 Middle East Prostate Cancer Drugs Consumption and Value Analysis

10.1.1 Middle East Prostate Cancer Drugs Market Under COVID-19

10.2 Middle East Prostate Cancer Drugs Consumption Volume by Types

10.3 Middle East Prostate Cancer Drugs Consumption Structure by Application

10.4 Middle East Prostate Cancer Drugs Consumption by Top Countries

10.4.1 Turkey Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.3 Iran Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.5 Israel Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.6 Iraq Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.7 Qatar Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.8 Kuwait Prostate Cancer Drugs Consumption Volume from 2016 to 2021

10.4.9 Oman Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 11 Africa Prostate Cancer Drugs Market Analysis

11.1 Africa Prostate Cancer Drugs Consumption and Value Analysis

11.1.1 Africa Prostate Cancer Drugs Market Under COVID-19

11.2 Africa Prostate Cancer Drugs Consumption Volume by Types

11.3 Africa Prostate Cancer Drugs Consumption Structure by Application

11.4 Africa Prostate Cancer Drugs Consumption by Top Countries

11.4.1 Nigeria Prostate Cancer Drugs Consumption Volume from 2016 to 2021

11.4.2 South Africa Prostate Cancer Drugs Consumption Volume from 2016 to 2021

11.4.3 Egypt Prostate Cancer Drugs Consumption Volume from 2016 to 2021

11.4.4 Algeria Prostate Cancer Drugs Consumption Volume from 2016 to 2021

11.4.5 Morocco Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 12 Oceania Prostate Cancer Drugs Market Analysis

12.1 Oceania Prostate Cancer Drugs Consumption and Value Analysis

12.2 Oceania Prostate Cancer Drugs Consumption Volume by Types

12.3 Oceania Prostate Cancer Drugs Consumption Structure by Application

12.4 Oceania Prostate Cancer Drugs Consumption by Top Countries

12.4.1 Australia Prostate Cancer Drugs Consumption Volume from 2016 to 2021

12.4.2 New Zealand Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 13 South America Prostate Cancer Drugs Market Analysis

13.1 South America Prostate Cancer Drugs Consumption and Value Analysis

13.1.1 South America Prostate Cancer Drugs Market Under COVID-19

13.2 South America Prostate Cancer Drugs Consumption Volume by Types

13.3 South America Prostate Cancer Drugs Consumption Structure by Application

13.4 South America Prostate Cancer Drugs Consumption Volume by Major Countries

13.4.1 Brazil Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.2 Argentina Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.3 Columbia Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.4 Chile Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.5 Venezuela Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.6 Peru Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Prostate Cancer Drugs Consumption Volume from 2016 to 2021

13.4.8 Ecuador Prostate Cancer Drugs Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Prostate Cancer Drugs Business

14.1 AbbVie

14.1.1 AbbVie Company Profile

14.1.2 AbbVie Prostate Cancer Drugs Product Specification

14.1.3 AbbVie Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Novartis

14.2.1 Novartis Company Profile

14.2.2 Novartis Prostate Cancer Drugs Product Specification

14.2.3 Novartis Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Johnson & Johnson

14.3.1 Johnson & Johnson Company Profile

14.3.2 Johnson & Johnson Prostate Cancer Drugs Product Specification

14.3.3 Johnson & Johnson Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Astellas Pharma

14.4.1 Astellas Pharma Company Profile

14.4.2 Astellas Pharma Prostate Cancer Drugs Product Specification

14.4.3 Astellas Pharma Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Merck Group

14.5.1 Merck Group Company Profile

14.5.2 Merck Group Prostate Cancer Drugs Product Specification

14.5.3 Merck Group Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Astra Zeneca

14.6.1 Astra Zeneca Company Profile

14.6.2 Astra Zeneca Prostate Cancer Drugs Product Specification

14.6.3 Astra Zeneca Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Bayer HealthCare

14.7.1 Bayer HealthCare Company Profile

14.7.2 Bayer HealthCare Prostate Cancer Drugs Product Specification

14.7.3 Bayer HealthCare Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 GlaxoSmithKline

14.8.1 GlaxoSmithKline Company Profile

14.8.2 GlaxoSmithKline Prostate Cancer Drugs Product Specification

14.8.3 GlaxoSmithKline Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Sanofi

14.9.1 Sanofi Company Profile

14.9.2 Sanofi Prostate Cancer Drugs Product Specification

14.9.3 Sanofi Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Amgen

14.10.1 Amgen Company Profile

14.10.2 Amgen Prostate Cancer Drugs Product Specification

14.10.3 Amgen Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Takeda Pharmaceuticals

14.11.1 Takeda Pharmaceuticals Company Profile

14.11.2 Takeda Pharmaceuticals Prostate Cancer Drugs Product Specification

14.11.3 Takeda Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Boehringer Ingelheim

14.12.1 Boehringer Ingelheim Company Profile

14.12.2 Boehringer Ingelheim Prostate Cancer Drugs Product Specification

14.12.3 Boehringer Ingelheim Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Ferring Pharmaceutical

14.13.1 Ferring Pharmaceutical Company Profile

14.13.2 Ferring Pharmaceutical Prostate Cancer Drugs Product Specification

14.13.3 Ferring Pharmaceutical Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Tokai Pharmaceuticals

14.14.1 Tokai Pharmaceuticals Company Profile

14.14.2 Tokai Pharmaceuticals Prostate Cancer Drugs Product Specification

14.14.3 Tokai Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Northwest Biotherapeutics

14.15.1 Northwest Biotherapeutics Company Profile

14.15.2 Northwest Biotherapeutics Prostate Cancer Drugs Product Specification

14.15.3 Northwest Biotherapeutics Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 BMS

14.16.1 BMS Company Profile

14.16.2 BMS Prostate Cancer Drugs Product Specification

14.16.3 BMS Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.17 Janssen Pharmaceuticals

14.17.1 Janssen Pharmaceuticals Company Profile

14.17.2 Janssen Pharmaceuticals Prostate Cancer Drugs Product Specification

14.17.3 Janssen Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.18 Foresee Pharmaceuticals

14.18.1 Foresee Pharmaceuticals Company Profile

14.18.2 Foresee Pharmaceuticals Prostate Cancer Drugs Product Specification

14.18.3 Foresee Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.19 Teva Pharmaceutical

14.19.1 Teva Pharmaceutical Company Profile

14.19.2 Teva Pharmaceutical Prostate Cancer Drugs Product Specification

14.19.3 Teva Pharmaceutical Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.20 Endo Pharmaceuticals

14.20.1 Endo Pharmaceuticals Company Profile

14.20.2 Endo Pharmaceuticals Prostate Cancer Drugs Product Specification

14.20.3 Endo Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.21 Spectrum Pharmaceuticals

14.21.1 Spectrum Pharmaceuticals Company Profile

14.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Specification

14.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Prostate Cancer Drugs Market Forecast (2022-2027)

15.1 Global Prostate Cancer Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Prostate Cancer Drugs Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Prostate Cancer Drugs Value and Growth Rate Forecast (2022-2027)

15.2 Global Prostate Cancer Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Prostate Cancer Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Prostate Cancer Drugs Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Prostate Cancer Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Prostate Cancer Drugs Consumption Forecast by Type (2022-2027)

15.3.2 Global Prostate Cancer Drugs Revenue Forecast by Type (2022-2027)

15.3.3 Global Prostate Cancer Drugs Price Forecast by Type (2022-2027)

15.4 Global Prostate Cancer Drugs Consumption Volume Forecast by Application (2022-2027)

15.5 Prostate Cancer Drugs Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology